首页> 外国专利> Agents against theileriosis e.g. in the form of drench - contg. 3-piperidinyl-acetonyl-quinazolin-4(3H)-one deriv. in form of its lactate, acetate or aceturate salt

Agents against theileriosis e.g. in the form of drench - contg. 3-piperidinyl-acetonyl-quinazolin-4(3H)-one deriv. in form of its lactate, acetate or aceturate salt

机译:抗胆汁增多症的药物,例如以湿透的形式-续3-哌啶基-丙酮基-喹唑啉-4(3H)-一衍生物。以其乳酸盐,乙酸盐或乙酸盐的形式

摘要

New agents against theileriasis contain a 3-(3-(2-piperidinyl)- acetonyl) -4(3H)-quinazolinone deriv. (I) in admixture with a pharmaceutically usual carrier and/or constituent. In (I), R1 and R2 are halogen, CF3, 1-4C alkoxy or CH3; Y is O, S or NOH; R is OH or 1-4C acyloxy; and X is the anion of lactic acid, acetic acid or aceturic acid. Specific (I) rac-trans-7-bromo-6-chloro-3 (3-(3-hydroxy-2-piperidyl) acetonyl)-4(3H)-quinazolinone lactate, aceturate and acetate are claimed.The lactates, acetates and aceturates (I) have better solubility than the corresponding hydrochlorides and are suitable for oral admin. in the form of aq.-solns.
机译:对抗麻痹的新药物包括3-(3-(2-哌啶基)-丙酮基)-4(3H)-喹唑啉酮衍生物。 (I)与药学上常用的载体和/或成分的混合物。在(I)中,R 1和R 2为卤素,CF 3,1-4C烷氧基或CH 3; Y是O,S或NOH; R为OH或1-4C酰氧基; X是乳酸,乙酸或乙酸的阴离子。要求保护一种特定的(I)外消旋-反-7-溴-6-氯-3(3-(3-羟基-2-哌啶基)丙酮基)-4(3H)-喹唑啉酮乳酸酯,乙酸酯和乙酸酯。醋酸盐和醋酸盐(I)的溶解度比相应的盐酸盐好,适合口服。以水溶形式。

著录项

  • 公开/公告号DE3035567A1

    专利类型

  • 公开/公告日1982-05-06

    原文格式PDF

  • 申请/专利权人 HOECHST AG;

    申请/专利号DE19803035567

  • 发明设计人 SCHEINEBERHARDPROF.DR.;

    申请日1980-09-20

  • 分类号C07D401/06;

  • 国家 DE

  • 入库时间 2022-08-22 12:42:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号